Clinical Trials Directory

Trials / Completed

CompletedNCT03637166

Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo)

Acute Exposure to Hypoxia in Precapillary Pulmonary Hypertension: Physiological and Clinical Effects at Rest and During Exercise

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude ("Säntis"; 2500m above sea level) on pulmonary artery pressure and right heart function (echo)

Detailed description

Low altitude baseline measurements will be performed in Zurich (460m asl) including Echocardiography, Right heart catheterization, six-minute walk test (6MWT), pulmonary function test, clinical assessment and blood gas Analysis. Randomly assigned to the order of testing, the participants will be tested in Low Altitude (Zurich, 470m) and at High Altitude (2500m). Several times within the exposure, the pulmonary artery pressure (PAP) and the right heart function will be assessed by echo.

Conditions

Interventions

TypeNameDescription
OTHERAssessment at Low Altitude (470m above sea level)Assessment at Low Altitude (in Zurich; 470m above sea level) in order to compare this data with High altitude exposure
OTHERExposure to High Altitude (2500m above sea level)Exposure to High Altitude ("Säntis"; 2500m above sea level) for approximately 5 hours

Timeline

Start date
2018-07-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2018-08-17
Last updated
2020-01-07

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03637166. Inclusion in this directory is not an endorsement.